157 related articles for article (PubMed ID: 9153217)
1. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.
Kolev K; Tenekedjiev K; Komorowicz E; Machovich R
J Biol Chem; 1997 May; 272(21):13666-75. PubMed ID: 9153217
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
Komorowicz E; Kolev K; Machovich R
Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.
Kolev K; Komorowicz E; Owen WG; Machovich R
Thromb Haemost; 1996 Jan; 75(1):140-6. PubMed ID: 8713793
[TBL] [Abstract][Full Text] [Related]
4. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
Kolev K; Komorowicz E; Machovich R
Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
[TBL] [Abstract][Full Text] [Related]
5. [Hydrolysis of polymeric fibrin by plasmin, miniplasmin, microplasmin and trypsin].
Andrianov SI; Makogonenko EM; Kudinov SA
Ukr Biokhim Zh (1978); 1992; 64(3):14-20. PubMed ID: 1440960
[TBL] [Abstract][Full Text] [Related]
6. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
7. Flow rate-modulated dissolution of fibrin with clot-embedded and circulating proteases.
Komorowicz E; Kolev K; Léránt I; Machovich R
Circ Res; 1998 Jun; 82(10):1102-8. PubMed ID: 9622163
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic resistance conferred to fibrinogen by von Willebrand factor.
Tanka-Salamon A; Kolev K; Machovich R; Komorowicz E
Thromb Haemost; 2010 Feb; 103(2):291-8. PubMed ID: 20024497
[TBL] [Abstract][Full Text] [Related]
10. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
Lucas MA; Straight DL; Fretto LJ; McKee PA
J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
[TBL] [Abstract][Full Text] [Related]
11. [Role of the K4 and K5 plasmin heavy chain kringles in the fibrin clot structure destruction].
Andrianov SI; Makogonenko EM; Kudinov SA
Ukr Biokhim Zh (1978); 1992; 64(2):31-8. PubMed ID: 1413115
[TBL] [Abstract][Full Text] [Related]
12. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
Kolev K; Léránt I; Tenekejiev K; Machovich R
J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
15. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
Cheng AC; Tsai IH
Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characteristics of fibrinogen and fibrin hydrolysis by plasmin 1 and 2 and miniplasmin.
Kastrikina TF; Taran LD; Kudinov SA
Thromb Res; 1986 Mar; 41(5):681-8. PubMed ID: 2938303
[TBL] [Abstract][Full Text] [Related]
18. Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin.
Turner RB; Liu L; Sazonova IY; Reed GL
J Biol Chem; 2002 Sep; 277(36):33068-74. PubMed ID: 12080056
[TBL] [Abstract][Full Text] [Related]
19. Regulation of nonproteolytic active site formation in plasminogen.
Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
[TBL] [Abstract][Full Text] [Related]
20. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
